期刊文献+

湖北土家族健康妇女HPV16型E7抗原HLA-A*02限制性CTL表位肽初步筛选

Preliminary screen of the epitope peptide of HLA-A*02-restricted cytotoxic derived from the HPV16 E7 antigen in the Tu nationality of Hubei province
原文传递
导出
摘要 目的:初步筛选湖北省五峰县土家族健康妇女HPV16型E7抗原HLA-A*02限制性CTL表位肽。方法:采集湖北省五峰县土家族HLA-A*02健康妇女外周全血并分离单个核细胞(peripheral blood mononuclear cell,PBMC),以HPV16型E7肽作为抗原,与人PBMC共培养9d后,采用酶联免疫斑点法(enzyme-linked immunosorbent spot,EILSPOT)检测不同多肽刺激PBMC产生特异性免疫反应的差异,使用SPSS 16.0软件进行统计学分析。结果:实验组均能诱导PBMC产生特异性免疫应答,其中E741-55(PAGQAEPDRAHYNIV)和E751-65(HYNIVTFCCKCDSTL)免疫反应显著。经过方差分析,组间差异有统计学意义,F=155.3,P=0.001;对组间进行LSD检验,与阴性对照组相比,实验组差异均有统计学意义,P=0.003;其中,P2和P4与阴性对照组比较差异有统计学意义,P值分别为0.021和0.016。结论:E741-55(PAGQAEPDRAHYNIV)和E751-65(HYNIVTFCCKCDSTL)抗原性强,有可能作为该地区HPV感染治疗性肽疫苗的候选表位。 OBJECTIVE:To perliminary screen the healthy women of HPV16 E7 antigen HLA-A* 02-restricted CTL epitope peptides in the Tu nationality of Hubei province in China. METHODS:Peripheral blood mononuclear cell (PBMC) were collected from healthy women who had HLA-A* 02 allele,using ELISPOT to detect the specific immune response a- mong the different polypeptide which were treated as antigen co-cultured with human peripheral blood mononuclear cells nine days and predict the HPV16 E7 antigen HLA-A* 02-restricted CTL epitope. SPSS 16.0 was Used in analyses. RE- SULTS:The experiental gruops can induce specific immune response,in which E741-55 and E751-65 generated the most signifi- cant response. There were significant differences between the groups after analysis of variance (F= 155.3 ,P= 0. 001). Af- ter LSD test,there were statistically significant between the experiental gruops and negative control group (P= 0. 003);P2, P4 compared with the negative control group, the difference was most significant (P= 0. 021, P = 0. 016 ). CONCLU- SION: E7415s (PAGQAEPDRAHYNIV) and E751-65 (HYNIVTFCCKCDSTL) have antigenicity,and may he the candidates for development of peptide vaccine in the treatment of HPV infections.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2014年第3期183-186,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(30872935)
关键词 五峰县 土家族 人乳头瘤病毒 E7抗原 表位 Wu feng county Tu nationalit y human paillomavirus E7 antigen Epitopes
  • 相关文献

参考文献11

  • 1Preeth CP,Padmapriya R,Periasamy VS. Antiproliferative property of n-hexane and chloroform extracts of Anisomeles malabarica (L).R.Br.in HPV16-positive human cervical cancer cells[J].J Pharmacol Pharmacother,2012,(01):26-34.
  • 2Jin XW,Sikon A,Yen Lieberman B. Cervical cancer screening:Less testing smarter testing[J].{H}Cleveland Clinic Journal of Medicine,2011,(11):737-747.
  • 3Mizuuchi M,Hirohashi Y,Torigoe T. Novel oligomannose liposome-DNA complex DNA vaccination efficiently evokes antiHPV E6 and E7 CTL responses[J].{H}EXPERIMENTAL AND MOLECULAR PATHOLOGY,2012,(01):185-190.
  • 4Ren F,Xu Y,Mao L. Heat shock protein 110 improves the antitumor effects of the cytotoxic T lymphocyte epitope E7 (49-57) in mice[J].{H}CANCER BIOLOGY & THERAPY,2010,(02):134-141.
  • 5王临虹,邱琇,郑睿敏,狄江丽.我国宫颈癌流行病学状况及防治策略的回顾与展望[J].中国妇幼卫生杂志,2010,1(3):146-149. 被引量:76
  • 6Sasagawa T,Takagi H,Makinoda S. Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer[J].{H}Journal of Infection and Chemotherapy,2012,(06):807-815.
  • 7Ding Z,Ou R,Ni B. Cytolytic activity of the human papillomavirus type 16 E711-20 epitope-specific cytotoxic T lymphocyte is enhanced by heat shock protein 110 in HLA-A* 0201 transgenic mice[J].{H}Clinical and Vaccine Immunology,2013,(07):1027-1033.
  • 8Zhang L,Cheng D,Tao N. Distribution of HLA-A,-B and-DRB1 genes and haplotypes in the Tujia population living in the Wufeng Region of Hubei Province,China[J].PLoS One,2012,(06):e38774.
  • 9王又又,向群英,佘茜,谭云,刘忠,张蔚,陶宁,陈庆,魏芸,伍欣星.宫颈癌高发区妇女HPV感染及影响因素分析[J].中国公共卫生,2011,27(3):259-261. 被引量:58
  • 10徐云升,郝飞,宋志强,钟白玉,郝进,叶庆佾.HPV16E7抗原的HLA-A2限制性细胞毒性T淋巴细胞表位的筛选与鉴定[J].中华皮肤科杂志,2004,37(5):283-284. 被引量:6

二级参考文献20

  • 1邹春莲.影视阴道镜在子宫颈病变诊断中的应用[J].齐齐哈尔医学院学报,2004,25(8):907-909. 被引量:2
  • 2穆雅琴,赵富玺,郭俊成,刘润花.宫颈癌凋亡抑制因子表达与HPV_(16/18)感染相关性[J].中国公共卫生,2006,22(12):1416-1418. 被引量:9
  • 3朱静鸿,孙丽琪,刘晓杰.长春市1987~2004年宫颈癌患者死亡分析[J].中国妇幼保健,2006,21(24):3387-3388. 被引量:3
  • 4李明成,张晓英,郑华.子宫颈糜烂与生殖道人乳头瘤病毒感染关系[J].中国公共卫生,2007,23(8):951-952. 被引量:8
  • 5Cuzick J, Arbyn M, Sankaranarayanan R, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries [ J ]. Vaccine ,2008,26(S) : K29 - K41.
  • 6Garland SM, Brotherton JM, Skinner S, et al. Human papilloma-virus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention [ J ]. Vaccine, 2008,26 ( S ) : M80 - M88.
  • 7Thomas JO, Herrero R, Omigbodun AA, et al. Prevalence of papil-lomavirus infection in women in Ibadan, Nigeria: a population-based study [ J ]. Br J Cancer,2004,90 ( 3 ) :638 - 645.
  • 8Clifford GM, Smith JS,Plummer M,et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis[J]. Br J Cancer,2003,88( 1 ) :63 -73.
  • 9Van Dumin M, Snjijders PJ, Schrijnemakers HF, et al. Human papillomaviurs 16 load in normal and abnormal cervical scrapes:an indicator of CIN Ⅱ/Ⅲ and viral clearance[J]. Int J Cancer,2002, 98(4) :590 -595.
  • 10Fujie T, Tahara K, Tanaka F, et al. A MAGE-1-encoded HLAA24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes. Int J Cancer, 1999, 80:169-172.

共引文献137

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部